In June this year, Paul Henderson received test results showing elevated PSA (prostate-specific antigen) levels. In this ...

Adding a focal boost to standard external beam radiotherapy improves biochemical disease-free survival in patients with ...

Prostate cancer, once dismissed as a rarity in India, has now become one of the top three cancers in men in Mumbai, according ...

New analysis reveals enzalutamide significantly outperforms darolutamide in treating metastatic hormone-sensitive prostate ...

In the US, prostate cancer is the second leading cause of cancer death in men – but experts can’t agree about testing ...

The female prostate cancer most women don't know exists. Why Skene's gland cancer is one of the deadliest overlooked risks in women's health.

During a live event, Tian Zhang, MD, MHS, discussed options and recent trial data for treating metastatic hormone-sensitive ...

Prostate Cancer companies working in the treatment market are Telix Pharmaceuticals, Merck and Orion, Exelixis, Ipsen Pharma and Takeda, Pfizer, AstraZeneca, Kangpu Biopharmaceuticals, Merus, Blue ...

Men with low-volume metastatic prostate cancer typically get doublet therapy, which is a combination of two drugs that each starve tumors of testosterone, a hormone that prostate cancer needs to grow.

For patients facing advanced prostate cancer, the idea of surgery is not a one-size-fits-all solution. It’s a highly nuanced ...

If prostate cancer screening is a simple blood test and prostate cancer is easily treatable in early stages, why don’t more ...